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Background/aim: The aim of this study was to investigate alterations in voice parameters among patients using continuous positive
airway pressure (CPAP) for the treatment of obstructive sleep apnea syndrome.
Materials and methods: Patients with an indication for CPAP treatment without any voice problems and with normal laryngeal findings
were included and voice parameters were evaluated before and 1 and 6 months after CPAP. Videolaryngostroboscopic findings, a selfrated scale (Voice Handicap Index-10, VHI-10), perceptual voice quality assessment (GRBAS: grade, roughness, breathiness, asthenia,
strain), and acoustic parameters were compared.
Results: Data from 70 subjects (48 men and 22 women) with a mean age of 44.2 ± 6.0 years were evaluated. When compared with
the pre-CPAP treatment period, there was a significant increase in the VHI-10 score after 1 month of treatment and in VHI- 10 and
total GRBAS scores, jitter percent (P = 0.01), shimmer percent, noise-to-harmonic ratio, and voice turbulence index after 6 months of
treatment. Vague negative effects on voice parameters after the first month of CPAP treatment became more evident after 6 months.
Conclusion: We demonstrated nonsevere alterations in the voice quality of patients under CPAP treatment. Given that CPAP is a longterm treatment it is important to keep these alterations in mind.
Key words: Obstructive sleep apnea, CPAP, voice, acoustic analysis, subjective evaluation

1. Introduction
Obstructive sleep apnea syndrome (OSAS) is characterized
by recurrent episodes of sleep-related collapse of the
upper airway and is usually associated with loud snoring,
choking, and arousal episodes during sleep and increased
daytime sleepiness. In studies on different populations
in the 30–60-year age group, OSAS prevalence was
3.1%–7.5% in men and 2.1%–4.5% in women (1). Today
the gold-standard method in the diagnosis of OSAS
is polysomnography (PSG). Other than the general
preventative strategies recommended to all patients, the
most common and effective method of OSAS treatment
involves the application of continuous positive airway
pressure (CPAP) (2). A CPAP device is a machine that
transfers room air to the patient’s airway with an intended
pressure via a low resistance snout and mask, creating a
continuous positive pressure that keeps the upper airways
open (pneumatic splint) (3).
The three main functional systems involved in
voice production are air pressure and the vibratory and
* Correspondence: mustafa.kbb@gmail.com

resonating systems. The air pressure system includes the
diaphragm, abdominal muscles, chest muscles, and rib
cage and provides and regulates air flow and pressure to
cause vocal folds to vibrate. The larynx forms a vibratory
system, which changes air pressure to sound waves by
vibrating vocal folds (VFs) to produce voiced sound. The
resonating system (vocal tract) modifies, amplifies, and
transfers this immature voice to the person-specific voice.
It has previously been reported that patients with sleep
apnea/hypopnea syndrome who regularly used CPAP for
more than 4 h per night all showed an increase in upper
airway dimensions (4). CPAP treatment may result in
alterations in pulmonary functions and upper airway
narrowing. Moreover, air flow with positive pressure
produced by the CPAP device may cause microtrauma in
the VFs and dryness on the mucosal surface of the VFs.
This potential VF microtrauma and mucosal dryness
due to CPAP therapy may hamper the regular mucosal
waveform, resulting in dysphonia, because optimal voice
production depends on the viscoelastic characteristics of
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the vibrating mucosal tissue structure of the VFs (5). Voice
analyses of patients under CPAP therapy may give us an
idea about the validity of these possible effects, which are
not yet supported by firm evidence. The aim of this study
was thus to investigate the effects of CPAP therapy, which
is widely used for OSAS, on the voice.
2. Materials and methods
This prospective single-blinded clinical study was carried
out at the voice disorders unit of the otorhinolaryngology
and sleep disorders laboratory at a research hospital. It was
approved by the research ethics committee of the hospital
(11/10-11.11.2013). Each patient was verbally informed
about the study by the specialists and signed an informed
consent form.
All individuals participating in this study were selected
from a patient group (over 18 years old) diagnosed with
OSAS via PSG and offered CPAP treatment. All subjects
underwent an overnight in-laboratory diagnostic PSG with
a 64-channel PSG machine (Compumedics, Melbourne,
Australia). All subjects used nasal-CPAP without a
humidifier after a CPAP titration study. Demographic data
and variables related to CPAP (number of hours used per
night and CPAP pressure) were recorded. Patients who did
not use CPAP treatment compliantly (minimum 4 h per
night and 70% of all nights) or used CPAP for less than 6
months were excluded from the study.
A detailed medical and voice habituation history was
obtained via a questionnaire prepared for this study. A
detailed ear-nose-throat (including endoscopic nasal
cavity) and neurologic examination was performed.
The participants defined their voices as normal. A
videolaryngostroboscopic (VLS) examination, selfadministered questionnaire for voice problems, perceptual
voice quality assessment, and acoustic voice analysis were
performed before and after 1 and 6 months of CPAP
treatment.
Exclusion criteria related to the voice were as follows:
history of smoking; intensive alcohol consumption; being
a professional voice user; history of any respiratory,
neurological, psychiatric, or endocrinological diseases;
being over 60 years old (to avoid possible presbyphonia,
which may affect voice analysis); laryngeal surgery; head
and neck trauma; radiotherapy to the head and neck region;
chemotherapy; hearing impairment; presence of any VF
organic lesion; presence of obvious nasal obstructing
pathology like nasal polyposis; previous voice therapy/
vocal training; any vocally abusive or misuse behaviors;
and taking medications that may cause mucosal dryness
such as diuretics or antihistamines.
Self-assessment of voice quality was scored using the
Turkish version of the Voice Handicap Index-10 (VHI-10).
The VHI-10 is a questionnaire composed of 10 questions.
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Subjects award a score of 0–4 for each question. Higher
scores indicate greater problems (6).
Perceptual voice quality was evaluated using the
GRBAS scale by four experienced specialists who did
not know the subjects. The GRBAS scale is a reliable and
valid scale consisting of five parameters (grade, roughness,
breathiness, asthenia, strain) that is universally used in
the auditory-perceptual evaluation of voice quality. For
each parameter, four different scores from 0 to 3 are given
according to the severity of dysphonia (0 is normal, 1 is
slight degree, 2 is medium degree, and 3 is high degree of
severity) (7). GRBAS scores were given by judges listening
to samples (voice recordings) of a reading passage in
Turkish that comprised 219 words with rich and balanced
phonemes. Voice records were shuffled to prevent the
listener’s familiarity with voices and their order (possible
order effect). The consistency between evaluators was
analyzed using Fleiss’ kappa and intraclass correlation
prior to the study and it was found that this compatibility
between the evaluators was high (84%, P = 0.01). If the
subject’s initial VHI-10 score was ≥2 and the mean GRBAS
score was ≥1, the subject was not included in the study.
VLS examination was performed in three different
periods. There was no sign of upper airway infection during
any evaluation. The VLS procedure (Xion Endo-Strob DX,
Berlin, Germany) was performed by an otolaryngology
specialist who did not know the subjects (blindly on
shuffled video recordings) to evaluate VF movements and
the mucosal waveform. VLS evaluation was based on the
protocol of the European Laryngological Society (8). Basic
VLS parameters evaluated were glottic closure, regularity,
mucosal waveform, and symmetry. For each stroboscopic
parameter, a four-point grading scale (0, no deviance;
3, severe deviance with maximum total score of 12) was
used. The glottal gap was evaluated at the maximum closed
point of a vibratory cycle during patient’s modal pitch at
a comfortable intensity on a sustained vowel [i]. Type of
insufficient closure was not categorized if it was observed.
If a mucosal waveform irregularity was identified (any VLS
parameter with score of >1), the subject was not included
in the study.
Voice samples were recorded in a sound-insulated
room at a sound level at which the patients felt relaxed
while seated upright with a high-quality omnidirectional
microphone (Shure SM48, Niles, IL, USA). The distance
between the microphone and mouth was adjusted to
approximately 10 cm. The microphone was positioned
at an angle of 90° to the mouth. Each patient was given a
short practice period prior to the first recording to become
familiar with the procedure. The subject was instructed
to phonate a sustained vowel [a] at a habitual pitch and
comfortable loudness for at least 5 s. The task was repeated
three times by each subject and each trial was captured
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on hard disk at a 44.100-Hz sampling rate and 16-bit
resolution. Computerized Speech Lab (Kay PENTAX CSL
Model 4500, Montvale, NJ, USA) software (CSL main
program and MDVP) was used to capture and analyze
the voice samples. One second at the beginning and one
at the end of the analyzed voice samples were removed to
avoid unintended irregularities and variability on voicing
onset and offset. The mean values were then calculated for
each subject. Acoustic parameters of voice samples were
fundamental frequency (F0), sound pressure level (SPL),
jitter percent (Jitt), shimmer percent (Shimm), noiseto-harmonic ratio (NHR), and voice turbulence index
(VTI). Maximum phonation time (MPT) was calculated
as the longest possible duration of sustained vowel \a\ on a
continuous expiration after a maximum inspiration.
SPSS 20.0 (IBM Corp., Armonk, NY, USA) was used
for statistical analysis. The Shapiro–Wilk test was used
to assess normality. Differences between different time
periods within patients were evaluated by paired sample
t-test. Differences in voice parameter values related to
CPAP pressure were evaluated by independent sample
t-test. The numerical results are presented as mean ± SD.
Statistical significance was set at P < 0.05.
3. Results
A total of 112 volunteer patients with the defined criteria
were included in this study. Among these, 36 (32.1%) did
not use CPAP regularly for 6 months and 6 (5.3%) did not
come to the check-ups on time and so they were excluded.

The results reported in this manuscript were collected from
48 men (mean age: 43.5 ± 5.7 years) and 22 women (mean
age: 45.3 ± 6.8 years), giving a total of 70 patients (mean
age: 44.2 ± 6.0 years). The mean body mass index (BMI) of
patients was 32.8 ± 6.2 kg/m2 (min: 28, max: 41); the mean
apnea-hypopnea index (AHI) determined in PSG was 30.4
± 2.7 (min: 25, max: 37), nightly mean CPAP usage time
was 5.7 h (min: 4, max: 7), and mean pressure of CPAP
treatment was 10.9 ± 2.6 (min: 8, max: 16) cmH2O.
The voice-associated parameters determined in the
pre-CPAP treatment period and after 1 and 6 months of
treatment are summarized in Table 1 for men and women
separately. The P-values showing the statistical significance
of differences in these parameters determined in three
different periods are shown in Table 2. In all patients, the
VHI-10 score was significantly higher after 1 month of
treatment (3.4 ± 1.71) than in the pre-CPAP treatment (1.68
± 0.88) period (P = 0.014), and it was again significantly
higher (P = 0.000) after 6 months of treatment (6.30 ±
1.36). The mean GRBAS score, which was 0.89 ± 0.63 in
the pre-CPAP treatment period, increased slightly after
1 month of treatment (1.18 ± 0.46) and was significantly
higher (P = 0.013) after 6 months of treatment (3.04 ±
0.85). There were no significant alterations in the F0,
SPL, or MPT values. Regarding the perturbation (Jitt and
Shimm) and spectral parameters (NHR and VTI), there
were no significant differences between results obtained
in the pre-CPAP treatment period and after 1 month of
treatment; however, there was a significant difference after

Table 1. The vocal analysis parameters of subjects for three different periods.
Men
Pre-CPAP

Women
1 month

6 months

Pre-CPAP

1 month

6 months

VHI-10

1.84 ± 0.78

3.27 ± 1.32

6.63 ± 1.73

1.59 ± 1.05

3.62 ± 1.45

6.45 ± 1.71

GRBAS

0.96 ± 0.62

1.16 ± 0.61

2.97 ± 0.73

0.75 ± 0.28

1.22 ± 0.65

3.31 ± 1.76

F0

135.9 ± 20.2

137.3 ± 21.1

138.4 ± 20.9

212.6 ± 29.4

209.5 ± 28.1

213.7 ± 26.8

SPL

71.1 ± 3.2

70.3 ± 3.7

70.7 ± 3.6

67.8 ± 3.5

66.1 ± 2.1

68.1 ± 3.1

Jitt

0.56 ± 0.24

0.58 ± 0.21

0.82 ± 0.23

0.71 ± 0.28

0.69 ± 0.31

0.88 ± 0.27

Shimm

2.54 ± 0.52

2.76 ± 0.55

3.35 ± 0.55

2.51 ± 0.49

2.75 ± 0.57

3.34 ± 0.51

NHR

0.13 ± 0.01

0.12 ± 0.03

0.20 ± 0.09

0.13 ± 0.02

0.13 ± 0.04

0.18 ± 0.07

VTI

0.051 ± 0.01

0.052 ± 0.021

0.063 ± 0.01

0.05 ± 0.012

0.051 ± 0.01

0.062 ± 0.01

F1

707.2 ± 73.5

687.5 ± 78.3

685.7 ± 70

857.5 ± 72.1

842.6 ± 65

843 ± 58.1

F2

1391 ± 166

1354 ± 170

1344 ± 194

1877 ± 199

1863 ± 166

1864 ± 219

F3

2535 ± 215

2428 ± 167

2424 ± 156

2983 ± 184

2870 ± 226

2864 ± 209

MPT

18.6 ± 3.2

17.4 ± 2.6

18.9 ± 3.4

15.4 ± 2.9

16.7 ± 2.4

16.2 ± 2.5

VHI-10: Voice Handicap Index-10; SPL: sound pressure level; F0: fundamental frequency; Jitt: jitter percent; Shimm: shimmer percent;
NHR: noise-to-harmonic ratio; VTI: voice turbulence index; F1, 2, 3: first, second, and third formant frequency; MPT: maximum
phonation time. Values are expressed as mean ± SD.
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Table 2. P-values showing the significance of differences between vocal analysis parameters for
three different periods.
I

II

II

VHI-10

0.000 / 0.000

GRBAS

0.256† / 0.110*

0.000† / 0.015*

0.000† / 0.000*

F0

0.888 / 0.729

0.126 / 0.238

†

SPL

0.253† / 0.630*

0.245† / 0.913*

0.123† / 0.515*

Jitt

0.632 / 0.799

*

0.000 / 0.240

0.000† / 0.026*

Shimm

0.104† / 0.126*

0.000† / 0.000*

0.000† / 0.000*

NHR

0.256 / 0.942

*

0.000 / 0.020

0.000† / 0.040*

VTI

0.082† / 0.675*

0.046† / 0.053*

0.027† / 0.030*

F1

0.745 / 0.817

0.09 / 0.748

0.052† / 0.685*

F2

0.558† / 0.229*

0.065† / 0.743*

0.083† / 0.256*

F3

0.801 / 0.704

*

0.092 / 0.083

0.087† / 0.124*

MPT

0.466† / 0.563*

0.856† / 0.685*

0.640† / 0.514*

†

*

†

†

†

†

†

*

*

*

*

*

0.015 / 0.175
†

*

†

*

†

†

†

*

†

0.000† / 0.000*
0.149 / 0.629*

Comparisons of I: pre-CPAP with 1 month of therapy, II: 1 month with 6 months of therapy, III:
pre-CPAP with 6 months of therapy. VHI-10: Voice Handicap Index-10; SPL: sound pressure
level; F0: fundamental frequency; Jitt: jitter percent; Shimm: shimmer percent; NHR: noise-toharmonic ratio; VTI: voice turbulence index; F1, 2, 3: first, second, and third formant frequency;
MPT: maximum phonation time. Values are expressed as mean ± SD. P ≤ 0.05 indicates statistical
significance. †: P-value for difference between men, *: P-value for differences between women.

6 months (P = 0.01 for Jitt, P = 0.000 for Shimm, P = 0.021
for NHR, and P = 0.030 for VTI). Formant frequencies
were found to decrease over time, in both sexes, and this
decrease was not statistically significant.
The total score of the VLS evaluation before treatment
was 0.25. After 1 month of treatment it was 0.24 and after 6
months it was 0.43, with no significant difference between
evaluations. Regarding individual VLS parameters, there
was a significant increase only for the 6-month results for
the glottal closing score (0.21 for pre-CPAP, 0.23 after 1
month, and 1.1 after 6 months of treatment).
When the voice alterations of all patients were evaluated
according to the median CPAP treatment pressure value
of 9 cmH2O, there was no significant difference in voice
parameters of patients below or above this pressure level.
4. Discussion
OSAS is associated with increased mortality and morbidity.
CPAP remains the predominant treatment for OSAS
because it is efficient and safe (9). However, this method
may not offer a definite cure for patients and the necessity
of lifelong usage and its adverse effects cause adherence
problems. The main side effects of CPAP treatment related
to the upper airways are nasal/oral dryness, epistaxis, nose
and throat irritation, and insufflation of tear ducts and the
middle ear. There are also insufficient published data about
the effects of this treatment method on the voice. When
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compared with healthy individuals, some commonly
observed anatomical features of the upper airways of
OSAS patients are thickening of soft tissue of the soft
palate and pharynx wall, hypertrophy of the tonsils and
tongue root, and an elongated and flaccid velum. Some
studies have reported a decline in increased tissue bulk in
the vocal tract (probably due to a decrease in edema) and
an increase in the cross-sectional volume of the airways at
the pharynx and tongue root level with CPAP treatment
(10). As previously reported by Corda et al. this expansion
takes place not only during CPAP usage while sleeping
(mechanical effect) but also takes place while the patient
is awake (11). Distinctive frequency components in the
sound spectrum of voiced sound produced by resonating
system are formants. Formant frequencies could be
changed according to the dimensional features of the
resonator units (pharynx, oral and sinonasal cavity). With
a decrease in the cross-sectional area of the resonator
unit, formant frequency increases. After OSAS surgery,
alterations in these frequencies were reported (12). In this
study, there was a nonsignificant decrease in the first three
formant frequencies after CPAP treatment, which may be
an indirect sign of alterations in the upper airway crosssectional volume. In this study, the high BMI values of the
patients may be the reason for this result. Studies are also
required in nonobese OSAS patients to determine voice
alterations after CPAP treatment.

SAYLAM et al. / Turk J Med Sci
The ability to combine phonation with articulation
and resonance allows for human speech. Biomechanical
responses and adaptations at the VF level may accompany
the alterations in upper airway anatomy that take place after
CPAP treatment (5,12). Namely, voice production requires
that several mechanical properties be met. Favorable
pliability and vibratory capacity of the tissues of the VFs
is an essential part of voice production. Once air passes
between the VFs, the body-cover concept of phonation
takes effect. The body-cover theory describes the wave-like
motion of the loose mucosa of the VFs over the stiffer, more
densely organized vocal ligament and vocalis muscle. This
motion is known as the mucosal wave (13). A smooth and
moist VF mucosal surface is required to maintain proper
phonatory function. The surface of the VFs is covered by a
thin layer of liquid (the mucous blanket, sol and gel layers).
This layer serves as a physical and biochemical barrier
that protects the underlying tissue. It is also an important
factor for a healthy mucosal wave pattern that increases
the efficiency of VF oscillation and promotes normal
voice quality (14). However, this layer is highly sensitive
to irritants inhaled from the air (15). Besides, systemic
and superficial VF hydration is an important part of vocal
hygiene and it was reported by Witt et al. that superficial
dehydration of the VFs may decrease the amplitude and
frequency of the mucosal wave (16). The dry air with high
airflow rate produced by CPAP may adversely affect this
layer and destroy the vibratory pattern. This alteration
results in an increase in perturbation and some spectral
parameters in voice analysis, and in this study we also
found significant increases in the % Jitt, % Shimm, NHR,
and VTI values. Our results are consistent with those of
Hamdan et al., who reported an increase in shimmer and
RAP values after CPAP usage (17). A reduction in voice
quality after this alteration was also found in evaluations
made by both patients (VHI-10) and listeners (GRBAS).
Conversely, Atan et al. revealed that both subjective and
objective voice parameters had improved after CPAP
treatment in a study including 27 patients (18).
In our study, the mean total VHI-10 score after 6
months of CPAP treatment was 6.45 (max: 9), and the
GRBAS score was 3.31 (max: 5). These results are lower
than the mean total VHI-10 (>11 could be considered as
abnormal) and GRBAS scores reported in the literature
for patients with hoarseness. This decrease in perceived
voice quality is not at the same level of alterations found
in patients with organic benign VF pathologies (19,20).

Moreover, the lack of any alterations in MPT and SPL
(aerodynamic parameters) values may suggest that it is not
so much changes in pulmonary functions that may affect
the voice. However, MPT and SPL are also related to glottal
efficiency. Hence, other aerodynamic parameters involving
pulmonary function tests like averaged phonation air flow
could have been evaluated. This is a limitation of this
study. In our study, CPAP treatment did not cause severe
voice alteration in patients without any voice problems but
its probable effects on patients with voice problems are not
known. For that reason, studies about the effects of CPAP
treatment on patients with voice problems are warranted.
On the other hand, since such alteration, though mild,
may cause substantial problems in patients who use their
voices professionally, studies on this population are also
required.
The configuration of glottic closure is the shape of the
glottis at maximum closure. In VLS evaluation a complete
glottal closure was assumed when the visible glottis was
completely closed. It was thought that the mild increase
in glottal closing score on VLS, which was not at a
pathological level, may have been caused by an increase
in VF strain during voice production. This finding may
be associated with an increase in strain due to increase in
phonation threshold pressure for the production of normal
mucosal waves in the probable presence of VF surface
dryness due to an increase in surface resistance on the VFs.
Superficial VF dehydration results in decreased efficiency
of VF vibration and compromised voice quality. Ionic and
osmotic composition of airway surface liquid overlying
the VF impacts the ionic environment of underlying
tissue. This may cause epithelial cell damage. The relative
contribution and mechanisms affecting the VF surface
liquid await further study. Electroglottographic evaluation
may also be discussed for glottal closure assessment in
further studies (21).
In conclusion, patients without any voice problems
using 6 months of regular CPAP may have mild voice
disturbances after this treatment. This probable mild
unfavorable effect of CPAP treatment is not thought to
adversely affect the patients’ quality of life. However, this
effect of CPAP should be kept in mind when recommending
this treatment for professional voice users, and also in
patients who have organic VF problems. Further studies
should be done to investigate any precautions that may be
required and to compare the results of different treatment
methods in patients with and without dysphonia.
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